Dexamethasone suppresses monocyte chemoattractant protein‐1 production via mitogen activated protein kinase phosphatase‐1 dependent inhibition of Jun N‐terminal kinase and p38 mitogen‐activated protein kinase in activated rat microglia
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Microglial cells release monocyte chemoattractant protein‐1 (MCP‐1) which amplifies the inflammation process by promoting recruitment of macrophages and microglia to inflammatory sites in several neurological diseases. In the present study, dexamethasone (Dex), an anti‐inflammatory and immunosuppressive drug has been shown to suppress the mRNA and protein expression of MCP‐1 in activated microglia resulting in inhibition of microglial migration. This has been further confirmed by the chemotaxis assay which showed that Dex or MCP‐1 neutralization with its antibody inhibits the microglial recruitment towards the conditioned medium of lipopolysaccharide (LPS)‐treated microglial culture. This study also revealed that the down‐regulation of the MCP‐1 mRNA expression by Dex in activated microglial cells was mediated via mitogen‐activated protein kinase (MAPK) pathways. It has been demonstrated that Dex inhibited the phosphorylation of Jun N‐terminal kinase (JNK) and p38 MAP kinases as well as c‐jun, the JNK substrate in microglia treated with LPS. The involvement of JNK and p38 MAPK pathways in induction of MCP‐1 production in activated microglial cells was confirmed as there was an attenuation of MCP‐1 protein release when microglial cells were treated with inhibitors of JNK and p38. In addition, Dex induced the expression of MAP kinase phosphatase‐1 (MKP‐1), the negative regulator of JNK and p38 MAP kinases in microglial cells exposed to LPS. Blockade of MKP‐1 expression by triptolide enhanced the phosphorylation of JNK and p38 MAPK pathways and the mRNA expression of MCP‐1 in activated microglial cells treated with Dex. In summary, Dex inhibits the MCP‐1 production and subsequent microglial cells migration to the inflammatory site by regulating MKP‐1 expression and the p38 and JNK MAPK pathways. This study reveals that the MKP‐1 and MCP‐1 as novel mediators of biological effects of Dex may help developing better therapeutic strategies for the treatment of patients with neuroinflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Eljaschewitsch, E., Witting, A., Mawrin, C., Lee, T., Schmidt, P. M., Wolf, S., Hoertnagl, H., Raine, C. S., Schneider-Stock, R., Nitsch, R., et al. (2006) · Neuron · doi:10.1016/j.neuron.2005.11.027 · Cited by 445 · cited 5×
“To this end, the inhibition of JNK and p38 MAPK pathways by GCs has been found to be mediated via induction of MKP-1 (Chen et al. 2002; Engelbrecht et al. 2003; Kassel et al. 2001; Lasa et al. 2002).”
BackgroundInfluentialHayashi, M., Luo, Y., Laning, J., Strieter, R. M., & Dorf, M. E. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00064-9 · Cited by 226
Zhao, Q., Shepherd, E. G., Manson, M. E., Nelin, L. D., Sorokin, A., & Liu, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411760200 · Cited by 207
Roger, T., Chanson, A., Knaup‐Reymond, M., & Calandra, T. (2005) · European Journal of Immunology · doi:10.1002/eji.200535413 · Cited by 184 · cited 2×
“Several lines of evidence suggest that GCs induced sustained expression of MKP-1 in various cell lines such as Hela cells (Lasa et al. 2002), osteoblasts (Engelbrecht et al. 2003), macrophages (Roger et al. 2005; Waetzig et al. 2005) and epithelial cells (Imasato et al. 2002; Sakai et al. 2004).”
BackgroundGlucocorticoid therapy in neurologic critical care
Gomes, J. A., Stevens, R. D., Lewin, J. J., Mirski, M. A., & Bhardwaj, A. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000166389.85273.38 · Cited by 118
Cited by
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
Targeting p38 MAPK pathway for the treatment of Alzheimer's disease
Munoz, L., & Ammit, A. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.010 · Cited by 369
Redox Control of Microglial Function: Molecular Mechanisms and Functional Significance
Rojo, A. I., McBean, G., Cindric, M., Egea, J., López, M. G., Rada, P., Zarkovic, N., & Cuadrado, A. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5745 · Cited by 309
Anti-inflammatory functions of glucocorticoid-induced genes
Clark, A. R. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.04.013 · Cited by 274
Yuskaitis, C. J., & Jope, R. S. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.014 · Cited by 240
Metadata
- Authors
- Zhou, Y., Ling, E., & Dheen, S. T.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2007-02-26
- Volume
- 102
- Issue
- 3
- Pages
- 667-678
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1597420564
- Cited by
- 115
- References
- 7
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.